Novartis: all 3,900 studies
Page 30 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA VaccineCompletedNCT01098786
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedNCT01097096Phase 2
- Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced DyskinesiaCompletedNCT01092065Phase 2
- Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy PainCompletedNCT01089855Phase 4
- Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean FeverCompletedNCT01088880Phase 2
- Phase II Trial of AUY922 vs. Comparators in Advanced Gastric CancerCompletedNCT01084330Phase 2
- Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II HypertensionCompletedNCT01070030Phase 4
- Placebo Versus SBR759 in Lowering Phosphate in Dialysis PatientsCompletedNCT01069692Phase 3
- Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly SubjectsCompletedNCT01069367Phase 4
- Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01068613Phase 2
- Safety of BKM120 Monotherapy in Advanced Solid Tumor PatientsCompletedNCT01068483Phase 1
- Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure RegimenTerminatedNCT01067079
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant PatientsCompletedNCT01064791Phase 2
- Dose Escalation of HSP990 in Japan/KoreaTerminatedNCT01064089Phase 1
- Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal TranslocationCompletedNCT01058434Phase 2
- A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.CompletedNCT01056731Phase 4
- A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT01055483Phase 1
- A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS VaccineCompletedNCT01053767Phase 1
- A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS VaccineCompletedNCT01052935Phase 1
- A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's DiseaseCompletedNCT01047579Phase 4
- Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01044316Phase 3
- A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe ToxicityCompletedNCT01044186Phase 2
- Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNCT01040741
- Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit VaccineCompletedNCT01037855
- Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety StudyCompletedNCT01037829
- Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized RegimenCompletedNCT01037348Phase 2
- Safety and Efficacy of DNK333 in Atopic Dermatitis PatientsCompletedNCT01033097Phase 2
- Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid TumorsCompletedNCT01030055Phase 1
- Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy VolunteersWithdrawnNCT01026961Phase 1/2
- Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01025544Phase 3
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT01023685Phase 2
- Efficacy and Safety of QAX576 in Patients With Eosinophilic EsophagitisCompletedNCT01022970Phase 2
- Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing ChoreaTerminatedNCT01019473Phase 2
- A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune ToleranceCompletedNCT01018693Phase 2
- Utilisation of Angiox® in European PracticeCompletedNCT01011504
- Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic FunctionCompletedNCT01007968Phase 1
- A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesCompletedNCT01004224Phase 1
- Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)CompletedNCT01002924Phase 2
- Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric SubjectsCompletedNCT01000207Phase 2/3
- Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in AsthmaticsWithdrawnNCT00997477Phase 4
- Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal FunctionCompletedNCT00997399Phase 1
- Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult SubjectsCompletedNCT00996138Phase 2/3
- Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10CompletedNCT00992212Phase 2
- Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseCompletedNCT00991146Phase 3
- Safety and Efficacy of BFH772 in Psoriasis PatientsCompletedNCT00987870Phase 1/2
- Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid RecurrenceTerminatedNCT00987545Phase 2
- To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain PatientsCompletedNCT00986882Phase 2
- Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseCompletedNCT00986414Phase 2
- Intra-venous Zoledronic Acid Once YearlyCompletedNCT00984893
- Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected PatientsCompletedNCT00983060Phase 2
- Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeCompletedNCT00971906Phase 3
- Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of AgeCompletedNCT00971542Phase 3
- Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of AgeCompletedNCT00971100Phase 3
- Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeCompletedNCT00970177Phase 3
- Dose-Escalation Study in Advanced Colon Cancer PatientsCompletedNCT00969046Phase 1
- Pharmacokinetics of Everolimus in Subjects With Hepatic InsufficiencyCompletedNCT00968591Phase 1
- Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular DegenerationCompletedNCT00967213Phase 3
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting ConditionsCompletedNCT00960479Phase 1
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT00960310Phase 1
- Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting ConditionsCompletedNCT00960245Phase 1
- Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting ConditionsCompletedNCT00959933Phase 1
- Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)CompletedNCT00959439Phase 1
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT00959335Phase 1
- Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast CancerCompletedNCT00958971Phase 2
- Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly SubjectsCompletedNCT00956449Phase 2
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT00956410Phase 2
- To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting ConditionsCompletedNCT00947128Phase 1
- To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mgCompletedNCT00947076Phase 1
- To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting ConditionsCompletedNCT00947063Phase 1
- To Demonstrate the Effect of Food on the Bioavailability of GlipizideCompletedNCT00947024Phase 1
- To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg TabletsCompletedNCT00946790Phase 1
- To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting ConditionsCompletedNCT00946764Phase 1
- To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting ConditionsCompletedNCT00946751Phase 1
- To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mgCompletedNCT00946725Phase 1
- To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00946686Phase 1
- To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting ConditionsCompletedNCT00946621Phase 1
- To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg TabletsCompletedNCT00946608Phase 1
- To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol TabletsCompletedNCT00946504Phase 1
- To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal VolunteersCompletedNCT00946491Phase 1
- To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting ConditionsCompletedNCT00946465Phase 1
- To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting ConditionsCompletedNCT00946387Phase 1
- Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010CompletedNCT00945841Phase 3
- Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)CompletedNCT00942864Phase 3
- A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal TumorsCompletedNCT00940563Phase 2
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma PatientsCompletedNCT00940160Phase 1/2
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive PatientsCompletedNCT00939588Phase 2
- Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate HypertensionCompletedNCT00933920Phase 1
- Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal RhinitisCompletedNCT00929968Phase 2
- Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
- Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy SubjectsCompletedNCT00920933Phase 1/2
- Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly SubjectsCompletedNCT00918268Phase 2
- Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly SubjectsCompletedNCT00914771Phase 2
- To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting ConditionsCompletedNCT00914160Phase 1
- To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin TabletsCompletedNCT00914004Phase 1
- To Demonstrate the Relative Bioavailability of Atenolol TabletsCompletedNCT00913965Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted ConditionsCompletedNCT00913952Phase 1
- To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting ConditionsCompletedNCT00913887Phase 1
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting ConditionsCompletedNCT00913874Phase 1